Pulmonary alveolar pores and alveolar macrophage-mediated particle clearance
- PMID: 7114499
- DOI: 10.1002/ar.1092030208
Pulmonary alveolar pores and alveolar macrophage-mediated particle clearance
Abstract
Pulmonary alveolar macrophages (AM) are considered to have an essential role in alveolar clearance of particles. The AM occupy only a small portion of the alveolar surface and their number is probably lower than the number of alveoli. Even at realistic experimental exposures the number of deposited particles, which are distributed all over the lung surface, is orders of magnitude higher than the number of AM. Phagocytosis of deposited particles, however, is being accomplished rapidly within hours. Based on microscopic evidence, we suggest that alveolar pores serve as important passageways for AM by shortening the distance between particles and AM. Accordingly, the pores of Kohn may, in part, lend efficiency to the in vivo particle collection by AM.
Similar articles
-
Role of alveolar macrophage chemotaxis and phagocytosis in pulmonary clearance responses to inhaled particles: comparisons among rodent species.Microsc Res Tech. 1993 Dec 1;26(5):412-22. doi: 10.1002/jemt.1070260509. Microsc Res Tech. 1993. PMID: 8286787
-
Deposition and translocation of inhaled silica in rats. Quantification of particle distribution, macrophage participation, and function.Lab Invest. 1982 Dec;47(6):533-42. Lab Invest. 1982. PMID: 6292578
-
[The pores of Kohn in pulmonary alveoli].Bull Eur Physiopathol Respir. 1983 Jan-Feb;19(1):59-68. Bull Eur Physiopathol Respir. 1983. PMID: 6850150 French.
-
[Pneumological diagnostics by means of models aerosols. IV. Clearance of aerosol particles from the pulmonary alveoli. Foundations and first clinical results].Pneumologie. 2002 Aug;56(8):503-10. doi: 10.1055/s-2002-33310. Pneumologie. 2002. PMID: 12174336 Review. German.
-
Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.Inhal Toxicol. 1996;8 Suppl:73-89. Inhal Toxicol. 1996. PMID: 11542496 Review.
Cited by
-
Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.J Control Release. 2020 Oct 10;326:222-244. doi: 10.1016/j.jconrel.2020.07.011. Epub 2020 Jul 16. J Control Release. 2020. PMID: 32681948 Free PMC article. Review.
-
Correlation between particle size, in vivo particle persistence, and lung injury.Environ Health Perspect. 1994 Oct;102 Suppl 5(Suppl 5):173-9. doi: 10.1289/ehp.102-1567252. Environ Health Perspect. 1994. PMID: 7882925 Free PMC article.
-
Lysosomal Disorders Drive Susceptibility to Tuberculosis by Compromising Macrophage Migration.Cell. 2016 Mar 24;165(1):139-152. doi: 10.1016/j.cell.2016.02.034. Cell. 2016. PMID: 27015311 Free PMC article.
-
LungVis 1.0: an automatic AI-powered 3D imaging ecosystem unveils spatial profiling of nanoparticle delivery and acinar migration of lung macrophages.Nat Commun. 2024 Nov 27;15(1):10138. doi: 10.1038/s41467-024-54267-1. Nat Commun. 2024. PMID: 39604430 Free PMC article.
-
Emerging delivery approaches for targeted pulmonary fibrosis treatment.Adv Drug Deliv Rev. 2024 Jan;204:115147. doi: 10.1016/j.addr.2023.115147. Epub 2023 Dec 6. Adv Drug Deliv Rev. 2024. PMID: 38065244 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical